Related Experiment Videos
[Retroperitoneal malignant fibrous histiocytoma]
1Département de Gynécologie Obstétrique, Biologie de la Reproduction et Médecine Faetale, CHU Bretonneau, Tours.
Annales De Chirurgie
|January 1, 1997
Summary
Malignant fibrous histiocytoma (MFH) is a common adult soft tissue sarcoma, often misdiagnosed in the retroperitoneum due to non-specific signs. Early surgical resection is crucial for treatment, but prognosis remains poor.
Area of Science:
- Oncology
- Pathology
- Radiology
Background:
- Malignant fibrous histiocytoma (MFH) is the most frequent soft tissue sarcoma in adults.
- The extremities are the most common primary site, with rarer occurrences in the female retroperitoneum.
Observation:
- Clinical, radiographic, and CT findings for MFH are non-specific, complicating diagnosis.
- Histological examination is definitive for MFH diagnosis.
- Retroperitoneal MFH presents diagnostic challenges, potentially leading to errors.
Findings:
- Complete initial resection is vital for managing primary MFH.
- Radiation therapy and chemotherapy have limited efficacy in treating MFH.
- MFH is associated with a poor prognosis.
Implications:
- The rarity of MFH poses challenges for comprehensive study.
- Accurate and timely diagnosis through histology is critical.
- Further research into effective treatment modalities for MFH is warranted.